Manufacturer record
Relieve Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Relieve Pharmaceuticals (Himachal Pradesh) was declared Not of Standard Quality in January 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 225004007, Hydroxyzine HCl IP /BP (exp Jun 2027). CDTL Mumbai (CDSCO lab) found it not of standard quality: Appearance of solution. Listed in the January 2023 alert.
Records by type
1 record linked to Relieve Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Hydroxyzine HCl IP /BP | Batch 225004007Mfg Jul 2022 · Exp Jun 2027 | Appearance of solutionOther | CDTL MumbaiCDSCO lab | Jan 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.